Related Experiment Video
Updated: Jul 20, 2026
07:55
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Pathological and physiological functions of presenilins
Kulandaivelu S Vetrivel1, Yun-wu Zhang, Huaxi Xu
1Department of Neurobiology, Pharmacology and Physiology, The University of Chicago, Chicago, IL 60637, USA. vetrivel@uchicago.edu
Molecular Neurodegeneration
|August 26, 2006
Summary
Mutations in presenilin genes (PSEN1 and PSEN2) are key causes of early-onset Alzheimer's disease. These mutations disrupt gamma-secretase function, increasing harmful beta-amyloid peptide levels.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mutations in PSEN1 and PSEN2 genes are the primary cause of early-onset familial Alzheimer's disease.
- Presenilins (PS1 and PS2) are integral membrane proteins and the catalytic core of the gamma-secretase complex.
- Gamma-secretase cleaves amyloid precursor protein, releasing beta-amyloid peptides implicated in Alzheimer's pathogenesis.
Purpose of the Study:
- To review the biology of presenilin 1 (PS1).
- To elucidate the role of PS1 in gamma-secretase activity.
- To discuss recent cell biology findings regarding PS1 in Alzheimer's disease.
Main Methods:
- Literature review of studies on PSEN1, PSEN2, gamma-secretase, and Alzheimer's disease.
- Analysis of research on the function and cell biology of presenilins.
- Synthesis of findings linking PSEN1 mutations to Alzheimer's and frontotemporal dementia.
Main Results:
- PSEN1 and PSEN2 mutations lead to early-onset familial Alzheimer's disease by altering gamma-secretase activity.
- Pathogenic presenilin variants are associated with increased production of amyloidogenic Abeta42 peptides.
- PSEN1 mutations are also linked to familial frontotemporal dementia.
Conclusions:
- Presenilins are critical components of gamma-secretase, and their dysfunction drives key aspects of Alzheimer's disease pathogenesis.
- Understanding PS1 cell biology is crucial for developing therapeutic strategies against familial Alzheimer's disease.
- Further research into PS1 function may reveal insights into other neurodegenerative disorders like frontotemporal dementia.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...